PHARMACY

Upsher-Smith to present phase-3 trial data of experimental epilepsy drug

BY Alaric DeArment

MAPLE GROVE, Minn. – Drug maker Upsher-Smith Labs will present data from a late-stage trial of a drug for treating epilepsy, the company said Monday.

Upsher-Smith’s presentation of data from a phase-3 clinical trial of USL255 (topiramate extended-release) will take place at the American Epilepsy Society’s 67th annual meeting in Washington, which lasts from Dec. 6-10. Seven presentations will highlight results from the "PREVAIL" trial, while two additional presentations will feature phase-1 trial data on pharmacokinetics of USL255 when sprinkled onto food or swallowed intact.

"This year’s AES meeting marks the first time the findings from our phase-3 trial will be presented publicly," Upsher-Smith chief scientific officer William Pullman said. "We look forward to sharing data from the first global phase-3 clinical trial of an extended-release formulation of topiramate with the epilepsy community at this year’s annual meeting."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

N.J. specialty pharmacy wins URAC accreditation

BY Alaric DeArment

NEW YORK — URAC has granted accreditation to Parkway Pharmacy, a specialty pharmacy based in New Jersey.

The pharmacy said Monday that it had received URAC’s full Specialty Pharmacy Accreditation. Parkway was established in 2010.

"By applying for and receiving Specialty Pharmacy Accreditation, Parkway Pharmacy has demonstrated a commitment to quality health care," URAC COO William Vandervennet said. "Quality health care is crucial to our nation’s welfare, and it is important to have organizations that are willing to measure themselves against national standards."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

AmerisourceBergen launches new Pharmacy Ownership Program

BY Michael Johnsen

VALLEY FORGE, Pa. — AmerisourceBergen on Monday announced the launch of the company’s new Pharmacy Ownership Program, a new network with resources established to assist independent community pharmacists in selling their business to prospective buyers or expanding their current business to additional locations. In conjunction with the announcement, AmerisourceBergen launched Buysellpharmacy.com.

“We are committed to helping independent community pharmacies meet their business goals," AJ Caffentzis, SVP sales and marketing at Amerisource said. "We understand that the interest of a pharmacy owner may be different throughout the life of the business — whether a pharmacist is looking to expand their business to multiple locations, or looking to downsize in preparation for retirement and potentially sell their store,” he said. “Our team of experienced pharmacy ownership consultants is available to guide [a prospective owner] every step of the way and provide confidential assistance from the initial planning to final sale.”

Through the Pharmacy Ownership Program, current pharmacy owners who are looking to sell their business are matched with qualified buyers who are interested in purchasing an independent community pharmacy. AmerisourceBergen’s pharmacy ownership consultants assist both potential buyers and sellers, without a brokerage fee, to identify a location in the market area of interest, provide financing options with established bank partners, and finalize the sale.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?